These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22355905)

  • 41. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
    Xie J; Marijnissen JC; Wang CH
    Biomaterials; 2006 Jun; 27(17):3321-32. PubMed ID: 16490248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
    Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
    Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant therapy for brain tumor.
    Walker MD
    Int Adv Surg Oncol; 1980; 3():351-69. PubMed ID: 7005101
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
    Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P
    Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemotherapy of brain tumor (author's transl)].
    Hoshino T
    No To Shinkei; 1976 Aug; 28(8):739-50. PubMed ID: 799933
    [No Abstract]   [Full Text] [Related]  

  • 46. [Maintenance immunochemotherapy for gliomas (author's transl)].
    Kyuma Y; Nakajima F; Shinonaga M; Yamashita T; Kuwabara T
    Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1025-31. PubMed ID: 6172721
    [No Abstract]   [Full Text] [Related]  

  • 47. [Current Progress of Chemotheraphy for Glimoa].
    Narita Y
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):685-9. PubMed ID: 27459744
    [No Abstract]   [Full Text] [Related]  

  • 48. Usefulness of transplanted glioma cells in the subcutaneous tissue of the nude mice, for assessment of therapeutic effect of the anti-tumor chemotherapy.
    Shimura T; Nakazawa S; Aihara K; Asano G
    Nihon Ika Daigaku Zasshi; 1983 Feb; 50(1):142-4. PubMed ID: 6841570
    [No Abstract]   [Full Text] [Related]  

  • 49. Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.
    Lowenstein PR
    J Clin Oncol; 2010 Nov; 28(31):4670-3. PubMed ID: 20921460
    [No Abstract]   [Full Text] [Related]  

  • 50. Can a repurposed vaccine fight cancer?: Use of the poliovirus vaccine to target brain tumors draws interest.
    Printz C
    Cancer; 2018 Nov; 124(22):4273-4274. PubMed ID: 30500082
    [No Abstract]   [Full Text] [Related]  

  • 51. Delicate Balances in Cancer Chemotherapy: Modeling Immune Recruitment and Emergence of Systemic Drug Resistance.
    Tran AP; Ali Al-Radhawi M; Kareva I; Wu J; Waxman DJ; Sontag ED
    Front Immunol; 2020; 11():1376. PubMed ID: 32695118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive tests and infrequent events in cancer chemotherapy.
    Rozencweig M; Staquet M
    Recent Results Cancer Res; 1984; 94():174-83. PubMed ID: 6387832
    [No Abstract]   [Full Text] [Related]  

  • 53. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
    Hodge JW; Ardiani A; Farsaci B; Kwilas AR; Gameiro SR
    Semin Oncol; 2012 Jun; 39(3):323-39. PubMed ID: 22595055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing response to chemotherapy in malignant glioma: the role of steroids.
    Weller M
    Neurology; 1998 Apr; 50(4):1196; author reply 1197-8. PubMed ID: 9566438
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessing response to chemotherapy in malignant glioma: the role of steroids.
    Hess KR; Wong ET; Yung WK
    Neurology; 1998 Apr; 50(4):1197; disscussion 1197-8. PubMed ID: 9566439
    [No Abstract]   [Full Text] [Related]  

  • 56. New glioblastoma vaccine: safe and immunogenic in phase 1.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1427. PubMed ID: 25396227
    [No Abstract]   [Full Text] [Related]  

  • 57. On combining antineoplastic drugs with tumor vaccines.
    Terando A; Mulé JJ
    Cancer Immunol Immunother; 2003 Nov; 52(11):680-5. PubMed ID: 12955481
    [No Abstract]   [Full Text] [Related]  

  • 58. [Phase 1 of clinical trial: The issue of dose-escalating].
    Penel N
    Bull Cancer; 2016 Jun; 103(6):511-2. PubMed ID: 27312351
    [No Abstract]   [Full Text] [Related]  

  • 59. Brain cancer vaccine looks promising in small trial.
    Hum Vaccin; 2010 Jul; 6(7):524-5. PubMed ID: 20622518
    [No Abstract]   [Full Text] [Related]  

  • 60. 8-Azaguanine (NSC-749). I. Preclinical toxicity studies and a preliminary report on intrathecal perfusion therapy for patients.
    Rubin RC; Larson R; Rall DP
    Cancer Chemother Rep; 1966 Jul; 50(5):283-6. PubMed ID: 5952508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.